# Research

We perform research to help create actionable evidence in three key areas:

March 31, 2022

## Dyslipidemia / High Cholesterol: PGHD delivers valuable insights for cholesterol management

### Rapid Insights

- Quickly engage cohorts of individuals. Build your cohort based on therapeutic areas and demographics.
- Using data from wearable devices, capture near real-time measurements about an individual’s lived experience—like their activity and how they use devices.
- Correlate the data to key events.

### Objective

Identify and segment patients based on real world behaviors and disease impact.

### Value Delivered

Identify and segment patients based on real world behaviors and disease impact.

[talk to our team](https://legal@evidation.com/for-customers/contact-us) [View case study](https://legal@evidation.com/resources/cholesterol)

May 1, 2022

## Asthma — PGHD delivers a roadmap to optimal treatment

### Patient Segmentation and Identification

- Identify and describe target patients based on real world behaviors and disease impact
- Quantify how disease impacts an individual’s quality of life and activities of daily living.

### Objective

Identify and segment patients based on real world behaviors and disease impact.

### Value Delivered

Identify and segment patients based on real world behaviors and disease impact.

[talk to our team](https://legal@evidation.com/for-customers/contact-us) [View case study](https://legal@evidation.com/resources/asthma)

March 4, 2022

## Alzheimers Disease and MCI — Cognitive impairment & PGHD: Insights for better management

### Disease Event and Prevention Modeling

- Detect, describe, and predict disease events and changes in health status
- Measure disease progression and recovery over time

### Objective

Identify and segment patients based on real world behaviors and disease impact.

### Value Delivered

Identify and segment patients based on real world behaviors and disease impact.

[talk to our team](https://legal@evidation.com/for-customers/contact-us) [View case study](https://legal@evidation.com/resources/alzheimers)

## Recent Research and Publications

Stay up to date with our latest research on health outside clinic walls.

[May 27, 2026\
\
**ISPOR 2026 Recap: Understanding Health Between Visits** \
\
Evidation’s research at ISPOR 2026 highlighted the growing need for direct, longitudinal patient data to better understand real-world outcomes\
\

[December 4, 2025\
\
**Building with Patients: A Conversation with Rachel Sha, CEO of Vaxess Technologies** \
\
Vaxess Technologies CEO Rachel Sha shares how patient voices are driving new delivery solutions for anti-obesity medications, with the potential to dramatically expand access and improve adherence.\
\

[October 16, 2025\
\
**How Evidation is Reshaping Substance Use Disorder (SUD) Research** \
\
Evidation is developing a digital experience within the Evidation app, that will engage and educate individuals with SUD while collecting data to support the research and development needs of organizations developing treatments for SUD.  \
\

[View more](https://legal@evidation.com/resources?resources-category=publications)